suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

Inneholder sammendrag

Saved in:
Bibliographic Details
Published inScandinavian journal of trauma, resuscitation and emergency medicine Vol. 26; no. 1; p. 11
Main Authors Meyer, Jeppe, Alstrup, Morten, Rasmussen, Line Jee Hartmann, Schultz, Martin, Ladelund, Steen, Haupt, Thomas H, Tingleff, Jens, Iversen, Kasper, Eugen-Olsen, Jesper
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.02.2018
Springer Nature B.V
BioMed Central
BMC
Subjects
Acute Disease - mortality
Acute surgery
Adult
Aged
akuttbehandling
akuttkirurgi
Biomarker
Biomarkers - blood
biomarkører
Cancer
Cell receptors
Denmark - epidemiology
Elective surgery
Female
Forecasts and trends
Health aspects
Hospitalization
Hospitals
Humans
Kidney diseases
Male
Management
Middle Aged
Mortality
Original Research
Patients
post-operative mortality
Postoperative period
Prognosis
Receptors, Urokinase Plasminogen Activator - blood
Registration
Registries
Retrospective Studies
Risk Assessment
Risk prediction
Soluble urokinase plasminogen activator receptor
suPAR
Surgical Procedures, Operative - mortality
Survival Rate - trends
Denmark
Biomarker
Soluble urokinase plasminogen activator receptor
suPAR
Risk assessment
Risk prediction
Post-operative mortality
Acute surgery
Online AccessGet full text

Cover

More Information
Summary:Inneholder sammendrag
Bibliography:Vol. 26 (2018)
suPAR står for: Soluble urokinase plasminogen activator receptor
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1757-7241
1757-7241
DOI:10.1186/s13049-018-0478-1